Showing results (1311-1320 of 3,081) with videos related to
Sort By:
Pageof 309
Drug Safety|June 26, 2013
The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the NetherlandsSigrid Piening, Pieter A de Graeff, Sabine M J M Straus, et al.Drug Safety|October 30, 2013
Managing data quality for a drug safety surveillance systemAbraham G Hartzema, Christian G Reich, Patrick B Ryan, et al.Drug Safety|October 30, 2013
Empirical performance of the case-control method: lessons for developing a risk identification and analysis systemDavid Madigan, Martijn J Schuemie, Patrick B RyanDrug Safety|October 30, 2013
Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis systemMarc A Suchard, Ivan Zorych, Shawn E Simpson, et al.Drug Safety|October 30, 2013
Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis systemPatrick B Ryan, Martijn J Schuemie, David MadiganDrug Safety|October 30, 2013
Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis systemMartijn J Schuemie, David Madigan, Patrick B RyanDrug Safety|October 30, 2013
A comparison of the empirical performance of methods for a risk identification systemPatrick B Ryan, Paul E Stang, J Marc Overhage, et al.Drug Safety|November 1, 2013
Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control studyMaja Hellfritzsch Simonsen, Rune Erichsen, Trine Frøslev, et al.Drug Safety|December 19, 2014
Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms?Barbara Osimani, Fiorenzo MigniniDrug Safety|December 3, 2014
Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatmentRandy L Luciano, Mark A PerazellaPageof 309